TABLE 4.
Type of subjects | Type of study design | Sample size | Study results | Reference | AUC in the training cohort | AUC in the test cohort |
---|---|---|---|---|---|---|
Adult patients with CD | Retrospective multicenter study | 212 bowel lesions of 167 CD patients | This radiomic model enabled the accurate differentiation of moderate‐severe from non‐mild intestinal fibrosis in CD, showing remarkable robustness in different inflammatory severities, CD locations, and CT scanners | Li et al 53 | 0.888 | 0.832 |
Adult patients with CD | Retrospective multicenter study | 312 bowel segments of 235 CD patients | Based on the same patient cohorts mentioned above (reference 52 ), the diagnostic performance of the deep learning model developed by using a 3D deep convolutional neural network was not inferior to that of the radiomic model, but it was more time‐saving than the radiomic model (48.4 vs. 599.8 s) | Meng et al 54 | 0.828 | 0.811 |
Paediatric patients with CD | Retrospective single institution study | 64 bowel segments of 25 patients | Texture analysis of enteric phase T1‐weighted fat suppressed postcontrast MRI images can distinguish fibrotic from nonfibrotic strictures, providing a noninvasive biomarker of stricture composition that can guide therapy arrangement | Tabari et al 55 | NA | 0.995 |
Rat model of colitis | Retrospective animal study | 45 rat model of inflammation (10 control and 35 irradiated with visible lesions) | This approach offers practitioners a valuable tool to evaluate antifibrotic treatments under development and to extrapolate such noninvasive MRI scores model for patients with the aim of identifying early stages of fibrosis improving disease management | Morilla et al 56 | NA | 0.875 |
Abbreviations: AUC, area under the curve; CD, Crohn's disease; IBD, inflammatory bowel disease; MRI, magnetic resonance imaging.